108202-3
Ganglioside GD2 IgM Ab [Presence] in Serum by Immunoassay
Active
Part Descriptions
LP99610-5 Ganglioside GD2
Anti-ganglioside autoantibodies are one marker of multiple sclerosis (MS). In one study, about 30% of patients with MS had anti-GD2-like IgM autoantibodies, and some of those also had antibodies to GD1a and/or GD3. Presence of anti-GD2-like antibodies was associated with significantly more neurological disability compared to patients with MS that did not have anti-GD2-like antibodies. PMID: 16764343
Source: Regenstrief LOINC,
PMID: 16764343
LP222219-0 Ganglioside
A ganglioside molecule consists of a glycosphingolipid (ceramide and oligosaccharide) with one or more sialic acid residues linked to the sugar chain. Molecules with one sialic acid residue are called monosialogangliosides (GM), those with two are called disialogangliosides (GD), and those with three are trisialogangliosides (GT). Gangliosides without any sialic acid residues are called asialogangliosides, while those that do not have a ceramide N-acyl group are called lysogangliosides. The number that typically is included at the end of the name indicates the order in which the molecule was discovered. For example, GM2 is a ganglioside with one sialic acid residue that was the second GM to be identified.
Source: Regenstrief LOINC
LOINC Names Get Info
- Fully-Specified Name
- Ganglioside GD2 Ab.IgM:
PrThr: Pt: Ser: Ord: IA - Long Common Name
- Ganglioside GD2 IgM Ab [Presence] in Serum by Immunoassay
- Short Name
- GD2 Gangl IgM Ser Ql IA
- Display Name
- Ganglioside GD2 IgM IA Ql (S)
- Consumer Name Alpha Get Info
- Ganglioside GD2 IgM antibody, Blood
Part Model Get Info
- Component
- Ganglioside GD2 Ab.IgM
LP99615-4
- Analyte
- Ganglioside GD2 Ab.IgM
LP99615-4
- Challenge
- NULL
- Adjustment
- NULL
- Count
- NULL
- Property
- PrThr
LP217195-9
- Time
- Pt
LP6960-1
- Time Core
- Pt
LP6960-1
- Time Modifier
- NULL
- System
- Ser
LP7567-3
- System Core
- Ser
LP7567-3
- Super System
- NULL
- Scale
- Ord
LP7751-3
- Method
- IA
LP217197-5
Basic Attributes
- Class
- SERO
- Type
- Laboratory
- First Released
- Version 2.81
- Last Updated
- Version 2.81 (ADD)
- Order vs. Observation
- Both
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG51965-8 | Ganglioside GD2 Ab.IgM| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| el-GR | Greek (Greece) | Γαγγλιοσίδη GD2 Αντισώματα IgM: Synonyms: IA Ord PrThr Pt SERO Ανοσοσφαιρίνη M Αντίσωμα Αντισώματα IgM Γαγγλιοσίδη Γαγγλιοσίδη GD2 Ορός |
| es-ES | Spanish (Spain) | Gangliosido GD2 IgM: |
| et-EE | Estonian (Estonia) | Gangliosiid GD2 antikehad.IgM: Synonyms: Immuunglobuliin M Järgarvuline Juhuslik Seerum |
| fr-BE | French (Belgium) | Ganglioside GD2 Anticorps. IgM: Synonyms: Anticorps |
| fr-FR | French (France) | Ganglioside GD2 Ac IgM: |
| fr-CA | French (Canada) | Ganglioside GD2, IgM: |
| it-IT | Italian (Italy) | Ganglioside GD2 Ab.IgM: Synonyms: Anticorpi IgM anticorpo Immunoassay Presenza o Soglia Punto nel tempo (episodio) Siero Sierologia (anticorpi e la maggior parte degli ant |
| nl-NL | Dutch (Netherlands) | ganglioside GD2 As.IgM: Synonyms: antistof; |
| pl-PL | Polish (Poland) | Gangliozyd GD2 Ab.IgM: Synonyms: IgM Przeciwciała do gangliozydu GD2 Przeciwciała IgM do gangliozydu GD2 |
| ru-RU | Russian (Russian Federation) | Ганглиозид GD2 Ат.IgM: Synonyms: Антитело Порядковый Сыворотка Точка во времени; |
| tr-TR | Turkish (Turkey) | Gangliozid GD2 Ab.IgM: Synonyms: Ak Ak.IgM İmmünölçüm, immünoassay Mevcut |
| zh-CN | Chinese (China) | 神经节苷脂 GD2 抗体.IgM: Synonyms: Ab.IgM; |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
LOINC Copyright
Copyright © Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://